Legal Representation
Attorney
JOHN PAUL OLEKSIUK
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 17, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 11, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Dec 11, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Dec 11, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 11, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 10, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 10, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 10, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 17, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jun 17, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jun 17, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 17, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 29, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 27, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Dec 27, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Dec 27, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 16, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 14, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jun 14, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jun 14, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 27, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 17, 2022 | TMBN | T | TTAB RELEASE CASE TO TRADEMARKS | Loading... |
| Nov 17, 2022 | OP.D | T | OPPOSITION DISMISSED NO. 999999 | Loading... |
| Nov 17, 2022 | OP.T | T | OPPOSITION TERMINATED NO. 999999 | Loading... |
| Aug 17, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 12, 2021 | OP.I | T | OPPOSITION INSTITUTED NO. 999999 | Loading... |
| Jul 2, 2021 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Jun 22, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 22, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 2, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 18, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 7, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| May 7, 2021 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| May 7, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 7, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 5, 2021 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Nov 3, 2020 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Nov 3, 2020 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Nov 3, 2020 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Nov 2, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 2, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 2, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 6, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 6, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| May 6, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 6, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 6, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 6, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 6, 2020 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 5, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and development; medical and scientific research for development of pharmaceuticals and biologics for the treatment of diseases; provision of medical research and scientific research services and information in the field of pharmaceuticals, therapeutic preparations, and clinical trials; Medical and scientific research, namely, conducting clinical trials for others
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"